Product Information
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.4620 per EA under NDC 62756096983. Its NADAC has been published 445 times since Feb 14, 2018.
FDA first approved this application on Aug 5, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2; .5 mg/1; mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756096983
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA201633FDA Approved
8/5/2016
TE Code
AB
On Market Since
7/18/2017
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has been published 445 times since Feb 14, 2018, and over the history we have for it it has declined 81.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4620 per EA |
|---|---|
| All-time high | $2.4971 (Jun 13, 2018) |
| All-time low | $0.3740 (Nov 20, 2024) |
| 52-week high | $0.5463 |
| 52-week low | $0.4123 |
| Median price | $0.7432 |
| Average price | $0.9291 |
| Largest weekly change | +58.5% (Aug 21, 2024) |
| Weeks tracked | 445 |
| Tracking since | Feb 14, 2018 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.4620 per EA (NDC 62756096983), effective Aug 19, 2026.
How has the price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has declined 81.0%. It has been tracked across 445 weekly CMS publications since Feb 14, 2018.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
Since Feb 14, 2018, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has ranged from a low of $0.3740 (Nov 20, 2024) to a high of $2.4971 (Jun 13, 2018), with a median of $0.7432 per EA.
Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET (NDC 62756096983) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.